Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetrapropylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.59 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.41 |
| ▸ | CES2 | O00748 | 5/20 | 0.39 |
| ▸ | CES1 | P23141 | 5/20 | 0.39 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrapropylammonium SCHEMBL108342 | 0.91 | SLC22A1 (0.62) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Bicarbonate SCHEMBL8857012 | 0.90 | SLC22A1 (0.48) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL107313 | 0.89 | SLC22A1 (0.53) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL109162 | 0.88 | SLC22A1 (0.59) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL3282336 | 0.88 | SLC22A1 (0.59) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL106250 | 0.88 | SLC22A1 (0.59) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL108599 | 0.88 | SLC22A1 (0.67) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL29047727 | 0.88 | SLC22A1 (0.67) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL106182 | 0.86 | SLC22A1 (0.56) | SLC22A1FFAR3HDAC3HDAC1HDAC2 | |
| Tetrapropylammonium SCHEMBL107312 | 0.85 | SLC22A1 (0.62) | SLC22A1FFAR3HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561313-A | Method for synthesizing copper halide-based colloid nanocrystalline at room temperature and application | 浙江大学 | 2024-08-30 | — | — | CN | claimed |
| CN-107001171-B | Method for producing compound | 住友化学株式会社 | 2020-12-22 | — | — | CN | claimed |
| US-5693599-A | Flux washing agent | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1997-12-02 | — | — | US | claimed |
| EP-0269949-B1 | PROCESS FOR PRODUCING A HIGH PURITY QUATERNARY AMMONIUM HYDROXIDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1993-04-21 | — | — | EP | claimed |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20260103437-A1 | METHOD FOR PRODUCING PURIFIED QUATERNARY AMMONIUM COMPOUND AQUEOUS SOLUTION | TOKUYAMA CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| EP-4717720-A1 | CATALYST COMPOSITION, BLOCKED POLYISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION, COATING FILM, AND METHOD FOR FORMING COATING FILM | Tosoh Corporation (JP) | 2026-04-01 | — | — | EP | disclosed |
| EP-4700067-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPERSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-25 | — | — | EP | disclosed |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4692941-A2 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4692150-A1 | CURABLE COMPOSITION AND CURED PRODUCT OF SAME | DIC Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260029706-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPER STRAIGHT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-01-29 | — | — | US | disclosed |
| US-7128976-B2 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |
| US-6238272-B1 | COMPRISING COLLOIDAL SOLUTION OF SILICON OXIDE AND BUFFERING SOLUTION COMPOSED OF ALKALI, QUATERNARY AMMONIUM COMPOUND AND WEAK ACID, LIKE CARBONIC ACID; SLURRY OF LOW HEAVY METAL CONTAMINATION, STABILIZED PH AND HIGHER REMOVAL RATE | SPEEDFAM-IPEC CO LTD (JP) | 2001-05-29 | — | — | US | disclosed |
| US-5693599-A | Flux washing agent | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1997-12-02 | — | — | US | disclosed |
| US-5538832-A | Developing solution for producing printed circuit boards and a process for producing printed circuit boards wherein the developing solution comprises a quaternary ammonium hydroxide and a quaternary ammonium carbonate | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1996-07-23 | — | — | US | disclosed |
| EP-0046680-B1 | IMPROVED CATALYTIC HYDROGENATION OF GLYCOLALDEHYDE TO PRODUCE ETHYLENE GLYCOL | THE HALCON SD GROUP, INC. (US) | 1984-06-20 | — | — | EP | disclosed |
| US-4321414-A | IN THE PRESENCE OF A RUTHENIUM CATALYST | THE HALCON SD GROUP, INC. (US) | 1982-03-23 | — | — | US | disclosed |
| EP-0046680-A1 | Improved catalytic hydrogenation of glycolaldehyde to produce ethylene glycol | THE HALCON SD GROUP, INC. (US) | 1982-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103437-A1 | METHOD FOR PRODUCING PURIFIED QUATERNARY AMMONIUM COMPOUND AQUEOUS SOLUTION | RAB5IF, AP3D1, AP3S1 | SLC22A1 4239/4885FFAR3 1039/4885HDAC3 936/4885 |
| US-20260029706-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPER STRAIGHT | SMC2, F12, SMC1A | SLC22A1 2667/4885FFAR3 383/4885HDAC3 3988/4885 |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | EFNA1, EPHA4, ETV6 | SLC22A1 4619/4885FFAR3 2087/4885HDAC3 4451/4885 |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SMC1A, SPOUT1, LBR | SLC22A1 2467/4885FFAR3 110/4885HDAC3 2256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.